Section one: Contracting authority
one.1) Name and addresses
NHS Blood and Transplant
500 North Bristol Park
Bristol
BS34 7QH
Contact
Paul Jones
Country
United Kingdom
NUTS code
UKK11 - Bristol, City of
National registration number
NHS Blood and Transplant
Internet address(es)
Main address
Buyer's address
one.3) Communication
Additional information can be obtained from the above-mentioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Primary Blood Grouping Managed Service
Reference number
NHSBT1476
two.1.2) Main CPV code
- 73430000 - Test and evaluation
two.1.3) Type of contract
Services
two.1.4) Short description
This Prior Information Notice (PIN) follows 2020/S 247-615598 released on the 15 December 2020 and all information herein supersedes that of 2020/S 247-615598.This Prior Information Notice (PIN) is separate to any tender opportunity and not related in any form whatsoever to any subsequent activity that NHSBT may wish to pursue. The purpose of this PIN is to consult the market to improve NHSBT’s knowledge on the status of manufacturer(s) or economic operator(s) that can supply a commercially available automated, high-throughput blood and non-blood group testing equipment and gauge market interest in a new provision of this service. It is the intention of NHSBT to further consult and engage with only those manufacturer(s) and economic operator(s) who meet the outline requirements.
two.1.5) Estimated total value
Value excluding VAT: £30,000,000
two.1.6) Information about lots
This contract is divided into lots: No
two.2) Description
two.2.2) Additional CPV code(s)
- 38434520 - Blood analysers
- 33696200 - Blood-testing reagents
- 48921000 - Automation system
- 71632000 - Technical testing services
- 85111810 - Blood analysis services
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
two.2.4) Description of the procurement
NHSBT requires a direct contractual relationship with either the manufacturer or any other economic operator for a complete end-to-end integrated solution, which must include all the necessary equipment, installation, maintenance, consumables, reagents, software, including an inter-operability provision with NHSBT’s existing IT infrastructure, and an overall on-going support mechanism that may be required to carry out the necessary testing as stated below. All invitro diagnostic medical devices, for example, instruments, consumables and reagents must be CE/UKCA marked. GB will continue to recognise CE marking under the IVDD or IVDR until 30 June 2023 and from 1 July 2023 devices placed on the GB market must be UKCA marked under the UK MDR 2002 as amended. The end-to-end solution must be capable of producing test results in a format that can be utilised by NHSBT’s host IT system (PULSE) without the need for changes to PULSE. The testing equipment should also be compatible with NHSBT’s manufactured reagents and where possible, with those from third party reagent suppliers.NHSBT require a high throughput blood and non-blood donation screening for primary blood grouping testing system(s), for ABO and Rh D typing (as a minimum DIV, DV and DVI), antibody screening and red cell phenotyping including Rh for donor blood samples.As a minimum, the test system supplied must be capable of undertaking the testing of blood and non-blood donor samples and providing accurate results for the following:• ABO group• Rh phenotype D, C, c, E, e • Kell • Atypical antibody screen• High titre anti-A and anti-B screening• Red cell phenotypes S, s, Jka, Jkb (test system should include an option of Cw and M)All test protocols must be in accordance with the Guidelines for the Blood Transfusion service in the United Kingdom (https://www.transfusionguidelines.org/red-book) and rules and guidance for pharmaceutical manufacturers and distributors.The annual estimated throughput of the NHSBT primary automated blood sample testing equipment tests approximately 1,500,000 donations (of which ca. 1500 - 2100 are non-blood donors) are tested per annum across two NHSBT testing sites, namely Manchester and Filton. Expressions of interest should be e-mailed to paul.jones@nhsbt.nhs.uk by no later than 1200 hours on 27 October 2021.
two.3) Estimated date of publication of contract notice
14 October 2021
Section four. Procedure
four.1) Description
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: No